Hsu; Chung-Y

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hsu; Chung-Y.The latest application filed is for "method for obtaining pluripotent adult olfactory stem cell".

Company Profile

6.6.9

Hsu; Chung-Y - Taichung TW
Hsu; Chung-Y. - Taichung TW
Hsu; Chung-Y. - Taichung City TW
Hsu; Chung-Y - Taichung City TW
Hsu, Chung Y. - Chicago IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for treating multiple sclerosis Grant 11,110,129 - Shyu , et al. September 7, 2	2021-09-07
Methods for obtaining pluripotent adult olfactory stem cells from an olfactory mucosa tissue Grant 10,988,733 - Shyu , et al. April 27, 2	2021-04-27
Method For Obtaining Pluripotent Adult Olfactory Stem Cell App 20200277569 - Shyu; Woei-Cherng ; et al.	2020-09-03
Method For Enhancing Expression Of Insulin Like Growth Factor 1 Receptor In Mesenchymal Stem Cell, Method For Obtaining Mesenchy App 20200246388 - Kind Code	2020-08-06
Methods for treating a brain tissue damage by cultured adult pluripotent olfactory stem cells Grant 10,696,945 - Shyu , et al. June 30, 2	2020-06-30
Method for enhancing insulin like growth factor 1 receptor expression of mesenchymal stem cell, method for isolating mesenchymal stem cell, and use of mesenchymal stem cell Grant 10,660,918 - Shyu , et al.	2020-05-26
Method for Treating Multiple Sclerosis App 20190201450 - Shyu; Woei-Cherng ; et al.	2019-07-04
Bicyclic compound and pharmaceutical composition thereof for treating stroke and use thereof Grant 10,035,791 - Lee , et al. July 31, 2	2018-07-31
Composition Including Adult Pluripotent Olfactory Stem Cell, Method For Isolating Pluripotent Adult Olfactory Stem Cell, And Use Thereof App 20180187146 - SHYU; Woei-Cherng ; et al.	2018-07-05
Method For Enhancing Insulin Like Growth Factor 1 Receptor Expression Of Mesenchymal Stem Cell, Method For Isolating Mesenchymal Stem Cell, And Use Of Mesenchymal Stem Cell App 20180133259 - SHYU; Woei-Cherng ; et al.	2018-05-17
Bicyclic Compound And Pharmaceutical Composition Thereof For Treating Stroke And Use Thereof App 20170298049 - LEE; Kuo-Hsiung ; et al.	2017-10-19
20(S)-sulfonylamidine derivatives of camptothecin and the use thereof as a potent antitumor agent Grant 9,718,835 - Lee , et al. August 1, 2	2017-08-01
Mesenchymal Stem Cell, Method For Clonogenic Expansion Thereof, Method For Isolating Thereof, And Use Thereof App 20170020924 - SHYU; Woei-Cherng ; et al.	2017-01-26
Novel 20(s)-sulfonylamidine Derivatives Of Camptothecin And The Use Thereof As A Potent Antitumor Agent App 20160229862 - LEE; Kuo-Hsiung ; et al.	2016-08-11
Combination therapy with inhibitors of inducible nitric oxide synthase and alkylating agents App 20050203082 - Hsu, Chung Y. ; et al.	2005-09-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.